Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 1 | 169733631 | 5 prime UTR variant | C/A | snv | 8.3E-02 | 7.8E-02 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
1.000 | 0.080 | 1 | 169729780 | intron variant | C/T | snv | 0.36 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 1 | 169731361 | intron variant | T/A;C;G | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.040 | 1 | 169731361 | intron variant | T/A;C;G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.040 | 1 | 169731361 | intron variant | T/A;C;G | snv |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.040 | 1 | 169731361 | intron variant | T/A;C;G | snv |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.040 | 1 | 169681903 | intron variant | G/A | snv | 0.61 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 1 | 169728058 | missense variant | C/A;T | snv | 4.1E-06; 4.1E-06 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 1 | 169793666 | missense variant | T/A;G | snv | 4.1E-06; 0.19 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 1 | 169793666 | missense variant | T/A;G | snv | 4.1E-06; 0.19 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 1 | 169793666 | missense variant | T/A;G | snv | 4.1E-06; 0.19 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 1 | 169793666 | missense variant | T/A;G | snv | 4.1E-06; 0.19 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 1 | 169727805 | missense variant | G/A | snv | 0.14 | 0.11 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.160 | 1 | 169727805 | missense variant | G/A | snv | 0.14 | 0.11 |
|
Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.160 | 1 | 169727805 | missense variant | G/A | snv | 0.14 | 0.11 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.882 | 0.160 | 1 | 169727805 | missense variant | G/A | snv | 0.14 | 0.11 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.851 | 0.160 | 1 | 169691640 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.851 | 0.160 | 1 | 169691640 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.851 | 0.160 | 1 | 169691640 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.851 | 0.160 | 1 | 169691640 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.851 | 0.160 | 1 | 169691640 | 3 prime UTR variant | A/G | snv | 0.27 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.790 | 0.360 | 1 | 169704697 | missense variant | G/A;T | snv | 0.21; 3.2E-05 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.790 | 0.360 | 1 | 169704697 | missense variant | G/A;T | snv | 0.21; 3.2E-05 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.360 | 1 | 169704697 | missense variant | G/A;T | snv | 0.21; 3.2E-05 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.790 | 0.360 | 1 | 169704697 | missense variant | G/A;T | snv | 0.21; 3.2E-05 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 |